Brodalumab Subcutaneous and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Brodalumab Subcutaneous and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Kitabis Pak
- Brodalumab Subcutaneous-Kitabis Pak inhalation
- Brodalumab Subcutaneous-Klofensaid II
- Brodalumab Subcutaneous-Klonopin
- Brodalumab Subcutaneous-Klonopin Wafer
- Brodalumab Subcutaneous-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Brodspec
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Brom Mal Phenyl HCl Dex HBr
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Bromaline
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Bromaline DM
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Bromatan Plus
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Bromatan-DM